Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Citi
UBS
Accenture
Medtronic
Colorcon
Deloitte
Argus Health
QuintilesIMS

Generated: April 21, 2018

DrugPatentWatch Database Preview

THYREL TRH Drug Profile

« Back to Dashboard

When do Thyrel Trh patents expire, and when can generic versions of Thyrel Trh launch?

Thyrel Trh is a drug marketed by Ferring and is included in one NDA.

The generic ingredient in THYREL TRH is protirelin. There are four drug master file entries for this compound. Additional details are available on the protirelin profile page.
Summary for THYREL TRH
Drug patent expirations by year for THYREL TRH
Synonyms for THYREL TRH
(2S)-N-[(1S)-2-[(2S)-2-carbamoylpyrrolidino]-1-(1H-imidazol-5-ylmethyl)-2-keto-ethyl]-5-keto-pyrrolidine-2-carboxamide
(2S)-N-[(2S)-1-[(2S)-2-aminocarbonylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxidanylidene-propan-2-yl]-5-oxidanylidene-pyrrolidine-2-carboxamide
(2S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
(2S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
(Pyro)-L-glutamic acid-L-histidine-L-proline-NH2
(S)-N-((S)-1-((S)-2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)-5-oxopyrrolidine-2-carboxamide
1-(3-(1H-Imidazol-5-yl)-2-([(5-oxo-2-pyrrolidinyl)carbonyl]amino)propanoyl)-2-pyrrolidinecarboxamide #
1-[3-(1H-4-imidazolyl)-2-(5-oxotetrahydro-1H-2-pyrrolylcarboxamido)propanoyl]tetrahydro-1H-2-pyrrolecarboxamide
11096-37-0
117217-40-0
2-Pyrrolidinecarboxamide, N-[1-[(2-carbamoyl-1-pyrrolidinyl)carbonyl]-2-imidazol-4-ylethyl]-5-oxo-,
2-Pyrrolidinecarboxamide, N-[1-[(2-Carbamoyl-1-pyrrolidinyl)carbonyl]-2-imidazol-4-ylethyl]-5-oxo-, (S,S,S)-
22365-02-2
22365-17-9
24305-27-9
305T279
39422-15-6
5-Oxo-L-prolyl-L-histidyl-L-prolinamide
53935-32-3 (1:1 tartrate)
5Y5F15120W
77666-61-6
9015-91-2
A-38579
AB0011512
Abbott 38579
ABBOTT-38579
AC1LCWUZ
AKOS015994636
AM001511
BDBM50072394
C03958
C16H22N6O4
CAS-24305-27-9
CCRIS 2593
CHEBI:35940
CHEMBL1472
CP-236
CS-7080
D00176
D08BTB
D0E9TD
DB09421
DSSTox_CID_3533
DSSTox_GSID_23533
DSSTox_RID_77067
DTXSID0023533
EINECS 246-143-4
FDA 1725
FT-0638410
FT-0639185
GTPL2139
HE299472
Hirtonin
HS-2023
HY-P0002
KS-00002WUW
L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-
L-Pyroglutamyl-L-histidinyl-L-prolinamide
L-Pyroglutamyl-L-histidyl-L-prolinamide
L-Pyroglutamyl-L-histidyl-L-proline amide
L-Pyroglutamyl-L-histidyl-L-prolineamide
Lopremone
MolPort-006-124-300
NCGC00160616-01
PR 546
PR-546
Prolinamide, 1-[N-(5-oxo-L-prolyl)-L-histidyl]-, L-
Prolinamide, 5-oxo-L-prolyl-L-histidyl-, L-
protirelin
Protirelin (JP17/USAN/INN)
Protirelin [USAN:INN:BAN:JAN]
Protirelin acetate
Protirelin tartrate
Protirelin, European Pharmacopoeia (EP) Reference Standard
Protirelina
Protirelina [INN-Spanish]
Protireline
Protireline [INN-French]
Protirelinum
Protirelinum [INN-Latin]
PyroGlu-His-prolinamide
pyroglutamyl-histidyl-prolinamide
Relefact TRH (TN)
Relefact-TRH
Rifathyroin
Ro 8-6270/9
s4680
SCHEMBL33419
Stimu-TSH
Synthetic thyrotopin releasing factor
Synthetic thyrotropin-releasing factor
Synthetic thyrotropin-releasing hormone
Synthetic TRF
Synthetic TRH
Synthetic tsh-releasing factor
Synthetic tsh-releasing hormone
Thypinone
Thyrefact
Thyroid releasing hormone
Thyroid-stimulating hormone-releasing factor
Thyroliberin
Thyrothropin relasing hormone
Thyrotrophic hormone releasing hormone
Thyrotrophin releasing hormone
Thyrotropic hormone-releasing factor
Thyrotropic hormone-releasing hormone
Thyrotropic releasing hormone
Thyrotropic-releasing factor
Thyrotropin releasing hormone
Thyrotropin releasing hormone, >=98% (HPLC), powder
Thyrotropin releasing hormone, powder, gamma-irradiated, cell culture tested
Thyrotropin-releasing factor
Thyrotropin-releasing factor (pig)
Thyrotropin-releasing hormone
Tox21_111939
TRF
TRH
trh-sr
TRH-SR, Takeda
TSH-releasing factor
TSH-releasing hormone
TSH-RF
UNII-5Y5F15120W
XNSAINXGIQZQOO-SRVKXCTJSA-N
ZINC4096261

US Patents and Regulatory Information for THYREL TRH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring THYREL TRH protirelin INJECTABLE;INJECTION 018087-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Baxter
Boehringer Ingelheim
Fish and Richardson
Dow
Farmers Insurance
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.